Scinai Immunotherapeutics Ltd (SCNI) Stock Analysis

Scinai Immunotherapeutics Ltd (SCNI) is a publicly traded company in the HEALTHCARE sector. It trades at $0.26, carries a market capitalization of $1.35M, a price-to-earnings ratio of 0.15. This page summarizes the public market data, fundamentals, and frequently asked questions for SCNI, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Price: $0.26
Market Cap: $1.35M
P/E Ratio: 0.15
EPS: $1.75
52-Week High: $2.41
52-Week Low: $0.24

Market Sentiment

Scinai Immunotherapeutics Ltd currently has a Bearish sentiment score of -0.25.

About Scinai Immunotherapeutics Ltd

None

GNG Research Analysis

GNG Research scores Scinai Immunotherapeutics Ltd (SCNI) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SCNI.

Frequently Asked Questions

Does SCNI pay dividends?

Scinai Immunotherapeutics Ltd (SCNI) does not currently pay a regular dividend.

What is SCNI's P/E ratio?

Scinai Immunotherapeutics Ltd has a price-to-earnings (P/E) ratio of 0.15.

What is SCNI's market cap?

Scinai Immunotherapeutics Ltd (SCNI) has a market capitalization of $1.35M with a current stock price of $0.26.